Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06014437
Status:
RECRUITING
Last Update Posted:
2023-08-28
First Post:
2023-08-17
Brief Title:
Study on Regeneration of Skin Defects in Diabetic Ulcers Treated With New Electrospun Material PLCLFg
Sponsor:
Guili Wang
Organization:
Fudan University
Study Overview
Official Title:
Study on Regeneration of Skin Defects in Diabetic Ulcers Treated With New Electrospun Material Poly L-lactide-co-caprolactone and Formulated Porcine Fibrinogen
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective cohort studies through clinical trials Obtained a large amount of real-world data to explore the efficacy of PLCLFg dressings for specific clinical applications
Published 1 relevant SCIE paper Provide a large amount of data support for the application of PLCLFg dressing in diabetic foot ulcer wound repair through basic experimental and clinical experimental studies It can provide a practical and effective biomaterial for the treatment of clinical skin wound structure and function reconstruction make the patients wound healing as soon as possible benefit the general public reduce medical expenditure reduce the burden on the society lay the foundation for the industrialization and marketization of national innovative medical devices and help to improve the international status and value of the application
Published 1 relevant SCIE paper Provide a large amount of data support for the application of PLCLFg dressing in diabetic foot ulcer wound repair through basic experimental and clinical experimental studies It can provide a practical and effective biomaterial for the treatment of clinical skin wound structure and function reconstruction make the patients wound healing as soon as possible benefit the general public reduce medical expenditure reduce the burden on the society lay the foundation for the industrialization and marketization of national innovative medical devices and help to improve the international status and value of the application
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None